Advertisement
Device Sectors
Subscribe to Device Sectors
View Sample

FREE Email Newsletter

Reducing Tube Current to Manage CT Radiation Dose

August 8, 2011 11:40 am | by Diagnostic Imaging | News | Comments

Using lower fixed-tube current or automatic exposure control techniques when performing adult and pediatric head CT scans can reduce radiation dose and ease concern about cancer risk, according to a recent study published in the Journal of the American College of Radiology.

Caliper, Carestream settle infringement lawsuits

August 8, 2011 9:38 am | by Mass High Tech: The Journal of New England Technology | News | Comments

Caliper Life Sciences Inc., a Hopkinton drug discovery firm, has settled two patent infringement lawsuits with Rochester, N.Y.-based Carestream Health Inc.

Symphony Corporation Acquires JGI to Provide End-to-End Services for Healthcare IT

August 8, 2011 8:47 am | by Bio-Medicine.Org | News | Comments

MADISON, Wis., Aug. 8, 2011 /- Symphony Corporation, a global healthcare technology solutions provider, today announced the acquisition of JGI, a New Jersey-based Human Capital Management consulting and technology firm with a significant presence in the healthcare industry nationally....

Advertisement

Endologix Announces First U.S. Implant of AFXâ„¢ Endovascular AAA System

August 8, 2011 8:47 am | by Bio-Medicine.Org | News | Comments

IRVINE, Calif., Aug. 8, 2011 /- Endologix, Inc. (Nasdaq: ELGX ), developer and marketer of minimally invasive treatments for aortic disorders, announced today that the first U.S. commercial implant of the Company's AFX™ Endovascular AAA System was performed at Edward Hines, Jr. VA...

Auxilium Pharmaceuticals, Inc. Announces Promotion of Dr. James P. Tursi to Chief Medical Officer

August 8, 2011 8:46 am | by Bio-Medicine.Org | News | Comments

MALVERN, Pa., Aug. 8, 2011 /- Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL ), a specialty biopharmaceutical company, today announced that Dr. James P. Tursi has been promoted to Chief Medical Officer. Dr. Tursi will report to Armando Anido, Chief Executive Officer and President of...

Spaulding Clinical Announces New Joint Partnership for Global Studies with Eurofins Optimed Clinical Research

August 8, 2011 8:46 am | by Bio-Medicine.Org | News | Comments

WEST BEND, Wis., Aug. 8, 2011 /- Eurofins Optimed Clinical Research, an experienced European clinical research service provider and Spaulding Clinical Research, LLC., US-based, leading-edge Clinical Pharmacology, Cardiac Core Lab, and Medical Device Manufacturer, announce a joint...

Carrot Medical Positioned for Third Straight Year of Triple Digit Growth

August 8, 2011 8:46 am | by Bio-Medicine.Org | News | Comments

BOSTON, Aug. 8, 2011 /- Carrot Medical, a leading manufacturer of integrated medical imaging display and communication systems, has announced results for Q2 2011. During the year, Carrot Medical achieved significant growth in sales and an expansion of sales channels. Concluding the first...

PET Parses Alzheimer's, Other Cognitive Impairments

August 8, 2011 8:43 am | by Diagnostic Imaging | News | Comments

Positron emission tomography (PET) scans using F-18 florbetaben (18F-FDG) clearly distinguished patients with Alzheimer's disease from those with frontaltemporal lobar degeneration (FTLD) and other cognitive impairments, according to a study in the Journal of Nuclear Medicine.

Advertisement

Saladax Biomedical, Inc. Enters Agreement with Kaan Medikal for Distribution of My5-FU in Turkey

August 8, 2011 8:43 am | by Bio-Medicine.Org | News | Comments

BETHLEHEM, Pa., Aug. 8, 2011 /- Saladax Biomedical, Inc., a privately held company developing and commercializing novel diagnostic assays to achieve the promise of personalized medicine for new and existing therapeutics, announced today that Kaan Medikal will serve as the exclusive...

Alere bumps up its stake in Axis-Shield stock

August 8, 2011 6:39 am | by Mass High Tech: The Journal of New England Technology | News | Comments

After confirming Friday its $375 million offer to acquire the outstanding shares of Scottish life sciences company Axis-Shield Plc, Waltham-based Alere Inc. announced today that it has increased its ownership stake of the company's shares from 2.23 percent to 6.4 percent.

Caliper and Carestream Settle Lawsuits

August 8, 2011 6:39 am | by Bio-Medicine.Org | News | Comments

HOPKINTON, Mass., Aug. 8, 2011 /- Caliper Life Sciences, Inc. (NASDAQ: CALP ) today announced that it has favorably settled two lawsuits with Carestream Health, Inc. In the first lawsuit, filed in February 2010, Caliper, its wholly owned subsidiary, Xenogen, and Stanford University...

Cardica to Present at the Wedbush Life Sciences Management Access Conference

August 8, 2011 5:39 am | by Bio-Medicine.Org | News | Comments

REDWOOD CITY, Calif., Aug. 8, 2011 /- Cardica, Inc. (Nasdaq: CRDC ) today announced that Bernard A. Hausen, M.D., Ph.D., the company's president and chief executive officer, is scheduled to present a corporate overview and update at the Wedbush 2011 Life Sciences Management Access...

Researchers Find RapidArc® Radiotherapy from Varian Medical Systems Can Quickly and Accurately Deliver Total Marrow Irradiation (TMI) Treatments for Patients with Blood Cance...

August 8, 2011 5:38 am | by Bio-Medicine.Org | News | Comments

PALO ALTO, Calif., Aug. 8, 2011 /- RapidArc® radiotherapy from Varian Medical Systems (NYSE: VAR ) can be used to treat patients with blood cancers by quickly and accurately delivering "clinically favorable" total marrow irradiation (TMI), according to a team of noted cancer...

Advertisement

Abaxis Announces Stock Repurchase Program

August 8, 2011 5:38 am | by Bio-Medicine.Org | News | Comments

UNION CITY, Calif., Aug. 8, 2011 /- ABAXIS, Inc. (Nasdaq: ABAX ) today announced that its Board of Directors has approved the repurchase of up to an aggregate of $40,000,000 of its Common Stock.  The repurchases will be made from time to time on the open market at prevailing market...

Insmed Announces Financial Results for Second Quarter and Six-Months Ended June 30, 2011

August 8, 2011 5:35 am | by Bio-Medicine.Org | News | Comments

MONMOUTH JUNCTION, N.J., Aug. 8, 2011 /- Insmed Incorporated (Nasdaq CM: INSM), a biopharmaceutical company, today reported results for the second quarter and six-months ended June 30, 2011. Key Recent Highlights: Announced positive results through six cycles of data from the open-label...

Pharmasset to Present at Canaccord Genuity Growth Conference

August 7, 2011 10:40 pm | by Bio-Medicine.Org | News | Comments

PRINCETON, N.J., Aug. 7, 2011 /-- Pharmasset, Inc. (Nasdaq: VRUS ) announces that management will present at the Canaccord Genuity Growth Conference to be held August 10 to 11, 2011 at the Intercontinental Hotel, Boston, Massachusetts. Schaefer Price, Pharmasset's President and Chief...

Total Victory for Schering Plough Pharmaceutical Reps in National Suit for Overtime Pay(2)

August 7, 2011 7:42 pm | by Bio-Medicine.Org | News | Comments

NEW YORK, Aug. 7, 2011 /- Schering Plough pharmaceutical representatives won a complete victory in Federal Court in a Nationwide Collective Law Suit. The law firms of Joseph, Herzfeld, Hester & Kirschenbaum, Kingsley & Kingsley and attorney Michael Dichiara represent the...

MRI Safety: Monitoring Body Temperature During MRI

August 6, 2011 6:34 pm | by Diagnostic Imaging | News | Comments

This monograph focuses on the need to monitor body temperature in patients during MRI and discusses the sites to record temperature based on efficacy and stability of the measurement, as well as the response time (i.e., the temporal resolution) during temperature fluctuations.

Poll of the Week: Should the FDA's 510(k) Process be Scrapped?

August 6, 2011 6:34 pm | by Diagnostic Imaging | News | Comments

Should the process be scrapped? Vote here, and tell us what you think.

CORRECTED: Bionovo Announces Second Quarter 2011 Highlights and Financial Results

August 5, 2011 7:39 pm | by Bio-Medicine.Org | News | Comments

EMERYVILLE, Calif., Aug. 5, 2011 /- CORRECTED -- Bionovo, Inc. (NASDAQ: BNVI ) today announced second quarter highlights and financial results for the three months ended June 30, 2011. "We have made excellent progress on our menopausal hot flash drug candidate, MF101, or Menerba™,...

David J. Illingworth Appointed to Board of Directors for Varian Medical Systems

August 5, 2011 9:48 am | by Bio-Medicine.Org | News | Comments

PALO ALTO, Calif., Aug. 5, 2011 /- Varian Medical Systems, Inc. (NYSE: VAR ) today announced that David J. Illingworth, a former CEO and member of the Board of Directors for Smith & Nephew and veteran of more than 30 years of management in global medical device businesses, has been...

Belmont Instrument wins Dutch military order

August 5, 2011 9:42 am | by Mass High Tech: The Journal of New England Technology | News | Comments

Billerica-based blood-focused medical device company Belmont Instrument Corp. has won an order for 45 units of its Rapid Infuser technology from the Dutch military.

South Florida Radiation Oncology on the Forefront of Cancer Treatment with the TrueBeamâ„¢ Radiotherapy System from Varian Medical Systems

August 5, 2011 8:43 am | by Bio-Medicine.Org | News | Comments

BOCA RATON and JUPITER, Fla., Aug. 5, 2011 /- In a promising development for cancer patients in The Palm Beach area, South Florida Radiation Oncology announced today that it has acquired the TrueBeam system, an innovative system that enables a radically different approach to treating...

Important Information on the Medical Device User Fee Rates for FY2012

August 5, 2011 7:30 am | by U.S. Food & Drug Administration | News | Comments

This letter is to notify you of the fiscal year 2012, (October 1, 2011-September 30, 2012), fee rates and payment procedures for medical device user fees payable to the United States Food and Drug Administration, (US FDA).

Misonix Announces Update of Product Registration in Brazil

August 5, 2011 5:41 am | by Bio-Medicine.Org | News | Comments

FARMINGDALE, N.Y., Aug. 5, 2011 /- Misonix, Inc. (NASDAQ: MSON ), a medical device company that designs, manufactures and markets innovative therapeutic ultrasonic products worldwide for wound debridement, spinal surgery, cosmetic surgery, neurosurgery, laparoscopic surgery, and other...

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading